2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; slv |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | WENGNER Antje-Margret BRIEM Hans LIENAU Philip MOOSMAYER Dieter KOPPITZ Marcus SIEMEISTER Gerhard VON NUSSBAUM Franz GRUDZINSKA-GOEBEL Joanna SCHICK Hans LEFRANC Julien EBERSPACHER Uwe LUCKING Ulrich EIS Knut BADER Benjamin WORTMANN Lars BONE Wilhelm |
description | The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib),
to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI3395818TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI3395818TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI3395818TT13</originalsourceid><addsrcrecordid>eNrjZFA10tXw9Q8K8PD38fTTNdGN9NHUNdQx1_VzDPAI8YgM8nTx9HMN5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8cGexsaWphaGFiEhhsbEqAEAb7sjTw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES</title><source>esp@cenet</source><creator>WENGNER Antje-Margret ; BRIEM Hans ; LIENAU Philip ; MOOSMAYER Dieter ; KOPPITZ Marcus ; SIEMEISTER Gerhard ; VON NUSSBAUM Franz ; GRUDZINSKA-GOEBEL Joanna ; SCHICK Hans ; LEFRANC Julien ; EBERSPACHER Uwe ; LUCKING Ulrich ; EIS Knut ; BADER Benjamin ; WORTMANN Lars ; BONE Wilhelm</creator><creatorcontrib>WENGNER Antje-Margret ; BRIEM Hans ; LIENAU Philip ; MOOSMAYER Dieter ; KOPPITZ Marcus ; SIEMEISTER Gerhard ; VON NUSSBAUM Franz ; GRUDZINSKA-GOEBEL Joanna ; SCHICK Hans ; LEFRANC Julien ; EBERSPACHER Uwe ; LUCKING Ulrich ; EIS Knut ; BADER Benjamin ; WORTMANN Lars ; BONE Wilhelm</creatorcontrib><description>The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib),
to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.</description><language>eng ; slv</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220131&DB=EPODOC&CC=SI&NR=3395818T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220131&DB=EPODOC&CC=SI&NR=3395818T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WENGNER Antje-Margret</creatorcontrib><creatorcontrib>BRIEM Hans</creatorcontrib><creatorcontrib>LIENAU Philip</creatorcontrib><creatorcontrib>MOOSMAYER Dieter</creatorcontrib><creatorcontrib>KOPPITZ Marcus</creatorcontrib><creatorcontrib>SIEMEISTER Gerhard</creatorcontrib><creatorcontrib>VON NUSSBAUM Franz</creatorcontrib><creatorcontrib>GRUDZINSKA-GOEBEL Joanna</creatorcontrib><creatorcontrib>SCHICK Hans</creatorcontrib><creatorcontrib>LEFRANC Julien</creatorcontrib><creatorcontrib>EBERSPACHER Uwe</creatorcontrib><creatorcontrib>LUCKING Ulrich</creatorcontrib><creatorcontrib>EIS Knut</creatorcontrib><creatorcontrib>BADER Benjamin</creatorcontrib><creatorcontrib>WORTMANN Lars</creatorcontrib><creatorcontrib>BONE Wilhelm</creatorcontrib><title>2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES</title><description>The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib),
to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFA10tXw9Q8K8PD38fTTNdGN9NHUNdQx1_VzDPAI8YgM8nTx9HMN5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8cGexsaWphaGFiEhhsbEqAEAb7sjTw</recordid><startdate>20220131</startdate><enddate>20220131</enddate><creator>WENGNER Antje-Margret</creator><creator>BRIEM Hans</creator><creator>LIENAU Philip</creator><creator>MOOSMAYER Dieter</creator><creator>KOPPITZ Marcus</creator><creator>SIEMEISTER Gerhard</creator><creator>VON NUSSBAUM Franz</creator><creator>GRUDZINSKA-GOEBEL Joanna</creator><creator>SCHICK Hans</creator><creator>LEFRANC Julien</creator><creator>EBERSPACHER Uwe</creator><creator>LUCKING Ulrich</creator><creator>EIS Knut</creator><creator>BADER Benjamin</creator><creator>WORTMANN Lars</creator><creator>BONE Wilhelm</creator><scope>EVB</scope></search><sort><creationdate>20220131</creationdate><title>2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES</title><author>WENGNER Antje-Margret ; BRIEM Hans ; LIENAU Philip ; MOOSMAYER Dieter ; KOPPITZ Marcus ; SIEMEISTER Gerhard ; VON NUSSBAUM Franz ; GRUDZINSKA-GOEBEL Joanna ; SCHICK Hans ; LEFRANC Julien ; EBERSPACHER Uwe ; LUCKING Ulrich ; EIS Knut ; BADER Benjamin ; WORTMANN Lars ; BONE Wilhelm</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI3395818TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>WENGNER Antje-Margret</creatorcontrib><creatorcontrib>BRIEM Hans</creatorcontrib><creatorcontrib>LIENAU Philip</creatorcontrib><creatorcontrib>MOOSMAYER Dieter</creatorcontrib><creatorcontrib>KOPPITZ Marcus</creatorcontrib><creatorcontrib>SIEMEISTER Gerhard</creatorcontrib><creatorcontrib>VON NUSSBAUM Franz</creatorcontrib><creatorcontrib>GRUDZINSKA-GOEBEL Joanna</creatorcontrib><creatorcontrib>SCHICK Hans</creatorcontrib><creatorcontrib>LEFRANC Julien</creatorcontrib><creatorcontrib>EBERSPACHER Uwe</creatorcontrib><creatorcontrib>LUCKING Ulrich</creatorcontrib><creatorcontrib>EIS Knut</creatorcontrib><creatorcontrib>BADER Benjamin</creatorcontrib><creatorcontrib>WORTMANN Lars</creatorcontrib><creatorcontrib>BONE Wilhelm</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WENGNER Antje-Margret</au><au>BRIEM Hans</au><au>LIENAU Philip</au><au>MOOSMAYER Dieter</au><au>KOPPITZ Marcus</au><au>SIEMEISTER Gerhard</au><au>VON NUSSBAUM Franz</au><au>GRUDZINSKA-GOEBEL Joanna</au><au>SCHICK Hans</au><au>LEFRANC Julien</au><au>EBERSPACHER Uwe</au><au>LUCKING Ulrich</au><au>EIS Knut</au><au>BADER Benjamin</au><au>WORTMANN Lars</au><au>BONE Wilhelm</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES</title><date>2022-01-31</date><risdate>2022</risdate><abstract>The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib),
to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; slv |
recordid | cdi_epo_espacenet_SI3395818TT1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
title | 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T08%3A13%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WENGNER%20Antje-Margret&rft.date=2022-01-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI3395818TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |